Industry

Shionogi and NHS England have signed an agreement to begin an innovative subscription payment model for reimbursement of cefiderocol in England which ‘de-links’ payment from volume of use1 Shionogi recognises the UK’s leadership role in introducing the world’s first fully ‘delinked’ pilot reimbursement model; pull incentives like this are an important step in making the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Disposable Masks – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Disposable Masks estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$26.6 Billion by 2026, growing at a CAGR of 5.4% over the analysis period. Surgical Masks, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology Market Research Report by Tool (Chassis Organisms, Cloning Technology Kits, and Enzymes), Technology, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Synthetic Biology Market size was estimated at USD 16.95 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Single Cell Analysis Market Research Report by Product (Consumables and Instruments), Technology, Process, Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Single Cell Analysis Market size was estimated at USD 5,111.60 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Axial Spondyloarthritis Market – A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR … [Read more…]

GADx combines expertise in the development of rapid diagnostics (Mologic Ltd) with sustainable, volume manufacturing (Global Access Diagnostics) under one organisation First portfolio company of social enterprise Global Access Health (GAH) following acquisition of Mologic Focused on expanding equitable and affordable access to world-class medical technology in low- and middle-income countries, starting with diagnostics Delivering … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Cambridge Bioscience, a UK-based specialist distributor of life science … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation in-person of members of Sensorion’s senior management in the Inner Ear Disorder Therapeutics Summit, a … [Read more…]

OSAKA, Japan & GENEVA & BOSTON–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Shionogi) and the Global Antibiotic Research and Development Partnership (GARDP) have today announced the execution of a license and technology transfer agreement and, with the Clinton Health Access Initiative (CHAI), a collaboration agreement that aim to significantly transform the landscape of access to antibiotics for … [Read more…]

OSAKA, Japan & GENEVA & BOSTON–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Shionogi) and the Global Antibiotic Research and Development Partnership (GARDP) have today announced the execution of a license and technology transfer agreement and, with the Clinton Health Access Initiative (CHAI), a collaboration agreement that aim to significantly transform the landscape of access to antibiotics for … [Read more…]